🍂 Enjoy the Fall Season! 🍂
MindTheDesk

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production

Business Archived • September 21, 2026 • 9 views
Eli Lilly is trying to catch up in the GLP-1 pill market to Novo, which got a head start in the space.
Source: CNBC Top | https://search.cnbc.com/rs/search/combinedcms/view.xml?partnerId=wrss01&id=100003114 - Read Original
"Cardamom Spices and more to satisfy the tastebuds 100g $14.94"
"House Plans for Structures New and Old"

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"Retirement Health Care"
"Free Quote Today"